Pavmed Inc Stock Price Patterns
| PAVM Stock | USD 10.80 0.22 2.08% |
Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (9.60) | EPS Estimate Next Year (17.10) | Wall Street Target Price 285.0003 | Quarterly Revenue Growth (0.99) |
Using PAVmed hype-based prediction, you can estimate the value of PAVmed Inc from the perspective of PAVmed response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards PAVmed using PAVmed's stock options and short interest. It helps to benchmark the overall future attitude of investors towards PAVmed using crowd psychology based on the activity and movement of PAVmed's stock price.
PAVmed Implied Volatility | 0.0 |
PAVmed's implied volatility exposes the market's sentiment of PAVmed Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if PAVmed's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that PAVmed stock will not fluctuate a lot when PAVmed's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in PAVmed to buy its stock at a price that has no basis in reality. In that case, they are not buying PAVmed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PAVmed after-hype prediction price | USD 10.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out PAVmed Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PAVmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PAVmed After-Hype Price Density Analysis
As far as predicting the price of PAVmed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PAVmed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PAVmed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PAVmed Estimiated After-Hype Price Volatility
In the context of predicting PAVmed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PAVmed's historical news coverage. PAVmed's after-hype downside and upside margins for the prediction period are 0.53 and 25.24, respectively. We have considered PAVmed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PAVmed is not too volatile at this time. Analysis and calculation of next after-hype price of PAVmed Inc is based on 3 months time horizon.
PAVmed Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as PAVmed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PAVmed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PAVmed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.90 | 14.56 | 0.76 | 0.28 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.80 | 10.68 | 1.11 |
|
PAVmed Hype Timeline
PAVmed Inc is at this time traded for 10.80. The entity has historical hype elasticity of 0.76, and average elasticity to hype of competition of 0.28. PAVmed is anticipated to decline in value after the next headline, with the price expected to drop to 10.68. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.11%, whereas the daily expected return is at this time at 0.9%. The volatility of related hype on PAVmed is about 4727.27%, with the expected price after the next announcement by competition of 11.08. About 18.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PAVmed Inc recorded a loss per share of 12.0. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 2nd of January 2026. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out PAVmed Basic Forecasting Models to cross-verify your projections.PAVmed Related Hype Analysis
Having access to credible news sources related to PAVmed's direct competition is more important than ever and may enhance your ability to predict PAVmed's future price movements. Getting to know how PAVmed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PAVmed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DHAI | DIH Holdings US | 0.00 | 0 per month | 33.49 | 0.28 | 400.00 | (93.02) | 980.00 | |
| IINN | Inspira Technologies Oxy | 0.07 | 9 per month | 0.00 | (0.07) | 7.29 | (7.14) | 24.08 | |
| PTHL | Pheton Holdings Ltd | 0.05 | 6 per month | 6.77 | 0.02 | 6.56 | (9.84) | 136.77 | |
| TNON | Tenon Medical | (0.03) | 9 per month | 0.00 | (0.25) | 5.61 | (7.21) | 18.03 | |
| BMRA | Biomerica | 0.00 | 0 per month | 0.00 | (0.06) | 4.12 | (4.98) | 18.44 | |
| HSCS | Heart Test Laboratories | (0.05) | 7 per month | 5.11 | 0.02 | 11.07 | (7.86) | 26.18 | |
| SSKN | STRATA Skin Sciences | 0.00 | 0 per month | 0.00 | (0.16) | 7.35 | (7.30) | 18.95 | |
| APVO | Aptevo Therapeutics | 0.52 | 9 per month | 0.00 | (0.28) | 7.81 | (10.34) | 43.37 | |
| ADVB | Advanced Biomed Common | (0.02) | 5 per month | 0.00 | (0.18) | 8.11 | (9.68) | 28.22 | |
| BNR | Burning Rock Biotech | 2.54 | 7 per month | 6.76 | 0.19 | 18.91 | (13.63) | 50.29 |
PAVmed Additional Predictive Modules
Most predictive techniques to examine PAVmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PAVmed using various technical indicators. When you analyze PAVmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PAVmed Predictive Indicators
The successful prediction of PAVmed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PAVmed Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PAVmed based on analysis of PAVmed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PAVmed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PAVmed's related companies. | 2025 | 2026 (projected) | Dividend Yield | 2.98E-4 | 2.65E-4 | Price To Sales Ratio | 2.33 | 2.21 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out PAVmed Basic Forecasting Models to cross-verify your projections. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.